CT (Myfortic 360 mg)
Generic Name: mycophenolic acid
Pill imprint CT has been identified as Myfortic 360 mg.
Myfortic is used in the treatment of rejection prophylaxis; dermatomyositis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Myfortic 360 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- mycophenolic acid
- Imprint:
- CT
- Strength:
- 360 mg
- Color:
- Orange
- Size:
- 18.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Selective immunosuppressants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0386
- Inactive Ingredients:
- silicon dioxide
crospovidone
hypromelloses
ferric oxide red
ferric oxide yellow
lactose anhydrous
magnesium stearate
povidone k30
corn starch
titanium dioxide
More about Myfortic (mycophenolic acid)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
